These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 12905563)
21. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status. Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527 [No Abstract] [Full Text] [Related]
22. [Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma]. Li CR; Jiang WH; Feng XM; Guo YJ; Shi ZH; Zhou CW Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):557-60. PubMed ID: 16438857 [TBL] [Abstract][Full Text] [Related]
23. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Tez M; Zulfikaroglu B Cancer; 2008 Jun; 112(12):2820-1; author reply 2821. PubMed ID: 18465802 [No Abstract] [Full Text] [Related]
24. Chemoembolization of the liver after portal vein embolization: report of three cases. Wallace MJ; Ahrar K; Madoff DC J Vasc Interv Radiol; 2008 Oct; 19(10):1513-7. PubMed ID: 18760626 [TBL] [Abstract][Full Text] [Related]
25. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. Kothary N; Weintraub JL; Susman J; Rundback JH J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286 [TBL] [Abstract][Full Text] [Related]
27. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation]. Zhou DW; Zhang ZJ; Sun W Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):786-8. PubMed ID: 15949389 [No Abstract] [Full Text] [Related]
28. Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402). Doffoël M; Bonnetain F; Bouché O; Vetter D; Abergel A; Fratté S; Grangé JD; Stremsdoerfer N; Blanchi A; Bronowicki JP; Caroli-Bosc FX; Causse X; Masskouri F; Rougier P; Bedenne L; Eur J Cancer; 2008 Mar; 44(4):528-38. PubMed ID: 18242076 [TBL] [Abstract][Full Text] [Related]
29. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma. Kaibori M; Tanigawa N; Matsui Y; Kwon AH; Sawada S; Kamiyama Y Anticancer Res; 2004; 24(3b):1929-33. PubMed ID: 15274379 [TBL] [Abstract][Full Text] [Related]
30. The chance of further chemoembolization and intrahepatic disease control after radiotherapy to portal vein thrombus. Cheng JC Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1316. PubMed ID: 15001277 [No Abstract] [Full Text] [Related]
31. [Acute renal failure as a complication of transarterial chemoembolization in a patient with hepatocellular carcinoma]. La Spada E; La Spada M; Brusca T; Campagna ME; Di Gesaro V; Terranova A; Sandonato L; Soresi M Recenti Prog Med; 2007 Apr; 98(4):232-5. PubMed ID: 17547360 [TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis. Kim HC; Chung JW; Choi SH; Yoon JH; Lee HS; Jae HJ; Lee W; Park JH J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842 [TBL] [Abstract][Full Text] [Related]
33. Chemoembolization of hepatic malignancy. Gonsalves CF; Brown DB Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189 [TBL] [Abstract][Full Text] [Related]
35. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554 [TBL] [Abstract][Full Text] [Related]
36. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675 [TBL] [Abstract][Full Text] [Related]
37. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma. Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887 [No Abstract] [Full Text] [Related]
38. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255 [TBL] [Abstract][Full Text] [Related]
39. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Poon RT; Yu WC; Fan ST; Wong J Aliment Pharmacol Ther; 2004 Apr; 19(7):779-88. PubMed ID: 15043519 [TBL] [Abstract][Full Text] [Related]
40. [The treatment of hepatocellular carcinoma. New developments]. Kuiken SD; van Delden OM; Richel DJ; Jansen PL Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]